Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Movement Disorders : Official Journal of the Movement Disorder Society|June 19, 2019
Roles of the M<sub>4</sub> acetylcholine receptor in the basal ganglia and the treatment of movement disordersMark S Moehle, P Jeffrey ConnBiochemical Society Transactions|April 4, 2023
The muscarinic M4 acetylcholine receptor exacerbates symptoms of movement disordersNicole E Chambers, Michael Millett, Mark S MoehleJournal of Neural Transmission (Vienna, Austria : 1996)|June 21, 2024
Anticholinergic drugs for parkinsonism and other movement disordersPeter A LeWitt, Luke Hong, Mark S MoehleNeurology|February 12, 2016
Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriersKyle B Fraser, Mark S Moehle, Roy N Alcalay, et al.Plos One|March 25, 2026
M5 positive allosteric modulation alleviates parkinsonian motor deficitsNicole E Chambers, Dominic Hall, Morgan Kaplan, et al.Schizophrenia Research|January 24, 2012
Regional differences in expression of β-tubulin isoforms in schizophreniaMark S Moehle, Richard F Luduena, Vahram Haroutunian, et al.Proceedings of the National Academy of Sciences of the United States of America|June 14, 2014
Abrogation of α-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient ratsJoão P L Daher, Laura A Volpicelli-Daley, Jonathan P Blackburn, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 4, 2012
LRRK2 inhibition attenuates microglial inflammatory responsesMark S Moehle, Philip J Webber, Tonia Tse, et al.The Lancet. Neurology|February 8, 2022
Cholinergic system changes in Parkinson's disease: emerging therapeutic approachesNicolaas I Bohnen, Alison J Yarnall, Rimona S Weil, et al.Biorxiv : the Preprint Server for Biology|April 15, 2024
<i>G</i> α <i></i> Regulates Biochemical Signaling in Neurons Associated with Movement Control and InitiationMichael Millett, Anika Heuberger, Elisabeth Martin Castosa, et al.Pageof 3